News

Overeating? Less Protein Means More Fat

View on the News

Focus on Fatness, Not Weight Gain or BMI

The findings of Bray and colleagues "suggest that overeating low-protein diets may increase fat deposition, leading to loss of lean body mass, despite lesser increases in body weight," said Dr. Zhaoping Li and Dr. David Heber.

"Clinicians should consider assessing a patient’s overall fatness rather than simply measuring body weight or body mass index, and concentrate on the potential complications of excess fat accumulation. The goals for obesity treatment should involve fat reduction rather than simply weight loss, along with a better understanding of nutrition science," they noted.

Dr. Li and Dr. Heber are at the Center for Human Nutrition, University of California, Los Angeles. Dr. Heber reported ties to POM Wonderful, Herbalife, McCormick Spices, and the Obesity Society for Clinical Research. Dr. Li reported no financial conflicts of interest. These remarks were taken from their editorial accompanying Dr. Bray’s report (JAMA 2012;307:86-7).


 

FROM JAMA

Overeating on a diet low in protein caused less weight gain than overeating on a normal- or high-protein diet – but most of the body mass gained was fat, rather than the leaner muscle mass created by high-protein overeating, according to a report published in the Jan. 4 issue of JAMA.

The distinction is important, because accumulation of excess fat is associated with obesity-related medical conditions, while accumulation of muscle mass is beneficial, noted Dr. George A. Bray of Pennington Biomedical Research Center, Baton Rouge, La., and his associates (JAMA 2012;307:47-55).

Photo Imagedepotpro/iStock.com

The results "suggest that overeating low-protein diets may increase fat deposition, leading to loss of lean body mass, despite lesser increases in body weight."

Dr. Bray and his colleagues examined whether the level of dietary protein affected weight gain and body composition. Their randomized trial included 25 healthy, weight-stable adults (BMI 19-30 kg/m2) who lived under tightly controlled conditions in a metabolic unit for 10-12 weeks. During the first 2-4 weeks of the study – a weight stabilization period – the 16 men and 9 women (aged 18-35 years) consumed an isocaloric diet with 15% of energy from protein, 25% from fat, and 60% from carbohydrates.

During the final 8 weeks of the trial, subjects were deliberately overfed 40% more energy than was needed for weight maintenance, an excess of approximately 1,000 calories each day. During that overeating period, they were randomly assigned to diets containing 5% of energy from protein (the low-protein diet), 15% of energy from protein (the normal-protein diet), or 25% of energy from protein (the high-protein diet).

Body composition was measured by dual x-ray absorptiometry. The study subjects included 7 non-Hispanic whites, 16 blacks, and 2 Asians.

All the study subjects gained weight during the overeating period, and there were no significant differences in weight gain by subjects’ race or sex. That suggests that the data are generalizable to all races and both sexes.

The weight gain in the low-protein group was 3.16 kg, significantly less than the weight gain in the other two groups – 6.05 kg in the normal-protein group and 6.51 kg in the high-protein group.

In the low-protein group, more than 90% of the extra energy was stored as fat. In contrast, in the normal- and high-protein groups, only about 50% of the extra energy was stored as fat, while the remaining 50% was lean body mass.

The findings imply that a low-protein diet is metabolically different from a normal- or high-protein diet, the investigators added.

The study was supported in part by the U.S. Department of Agriculture and Louisiana State University, New Orleans. Dr. Bray reported ties to Abbott Laboratories, Takeda Global Research Institute, Medifast, Herbalife, and Global Direction in Medicine. One of his associates reported ties to Bristol-Myers Squibb, Eli Lilly, Elcelyx, Merck, Philips, the International Life Sciences Institute, Catapult Health, and Domain & Associates.

Recommended Reading

FDA Approves Juvisync for Diabetes, High Cholesterol
MDedge Cardiology
Stroke Risk Surges After 10 Years in Diabetes Patients
MDedge Cardiology
Cardiac Risk in Diabetes Often Overestimated
MDedge Cardiology
ACE Inhibitors May Prevent Bone Loss in Men
MDedge Cardiology
Weight Loss Modest With Primary Care Program
MDedge Cardiology
Remote Weight-Loss Program Effective Long-Term
MDedge Cardiology
Obese Children Who Lose Weight Decrease Future CV Risks
MDedge Cardiology
Diabetes: Calorie Restriction Yields Lasting Cardiac Benefit
MDedge Cardiology
Parathyroidectomy Improves Depression, Cardiovascular Abnormalities
MDedge Cardiology
Undiagnosed Diabetes Common in Women With Acute MI
MDedge Cardiology